Literature DB >> 12787047

Hypothalamic-pituitary-adrenal responses to centrally administered orexin-A are suppressed in pregnant rats.

P J Brunton1, J A Russell.   

Abstract

Orexins are hypothalamic neuropeptides that stimulate arousal and food intake but also activate the hypothalamic-pituitary-adrenal (HPA) axis. During late pregnancy in the rat, the responsiveness of the HPA axis to stressors is attenuated, and thus we investigated HPA axis responses to centrally administered orexin-A during pregnancy. Intracerebroventricular injection of orexin-A (0.5 micro g, 140 pmol) significantly increased plasma adrenocorticotropic hormone and corticosterone concentration within 10 min in virgin female Sprague-Dawley rats, but had no effect in day 21 pregnant rats. Orexin-A significantly increased corticotropin-releasing hormone (CRH) mRNA expression, measured by in situ hybridization, in the paraventricular nucleus (PVN) of the virgin group but not in the pregnant group. Thus, the responsiveness of PVN CRH neurones to orexin-A, and hence the pituitary-adrenal axis, is markedly reduced in pregnancy. This may favour anabolic adaptations in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787047     DOI: 10.1046/j.1365-2826.2003.01045.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  14 in total

Review 1.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 2.  Allopregnanolone modulation of HPA axis function in the adult rat.

Authors:  Giovanni Biggio; Maria Giuseppina Pisu; Francesca Biggio; Mariangela Serra
Journal:  Psychopharmacology (Berl)       Date:  2014-09       Impact factor: 4.530

3.  Orexin a stimulates hypothalamic-pituitary-adrenal (HPA) axis function, but not food intake, in the absence of full hypothalamic NPY-ergic activity.

Authors:  Griselda Moreno; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

4.  Neuroendocrine, Autonomic, and Metabolic Responses to an Orexin Antagonist, Suvorexant, in Psychiatric Patients with Insomnia.

Authors:  Masaru Nakamura; Takahiko Nagamine
Journal:  Innov Clin Neurosci       Date:  2017-04-01

5.  Endogenous opioids and attenuated hypothalamic-pituitary-adrenal axis responses to immune challenge in pregnant rats.

Authors:  Paula J Brunton; Simone L Meddle; Shuaike Ma; Tomasz Ochedalski; Alison J Douglas; John A Russell
Journal:  J Neurosci       Date:  2005-05-25       Impact factor: 6.167

Review 6.  Attenuated hypothalamo-pituitary-adrenal axis responses to immune challenge during pregnancy: the neurosteroid opioid connection.

Authors:  Paula J Brunton; John A Russell
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

Review 7.  No stress please! Mechanisms of stress hyporesponsiveness of the maternal brain.

Authors:  David A Slattery; Inga D Neumann
Journal:  J Physiol       Date:  2007-11-01       Impact factor: 5.182

8.  Hypothalamic orexin's role in exacerbated cutaneous vasodilation responses to an anxiogenic stimulus in a surgical menopause model.

Authors:  Lauren M Federici; Izabela Facco Caliman; Andrei I Molosh; Stephanie D Fitz; William A Truitt; Pascal Bonaventure; Janet S Carpenter; Anantha Shekhar; Philip L Johnson
Journal:  Psychoneuroendocrinology       Date:  2015-12-18       Impact factor: 4.905

9.  Prenatal Stress Alters Progestogens to Mediate Susceptibility to Sex-Typical, Stress-Sensitive Disorders, such as Drug Abuse: A Review.

Authors:  Cheryl A Frye; Jason J Paris; Danielle M Osborne; Joannalee C Campbell; Tod E Kippin
Journal:  Front Psychiatry       Date:  2011-10-17       Impact factor: 4.157

10.  Neonatal overfeeding alters adult anxiety and stress responsiveness.

Authors:  Sarah J Spencer; Alan Tilbrook
Journal:  Psychoneuroendocrinology       Date:  2009-03-20       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.